MDMA Therapy in Veterans With PTSD

Recruiting now · Phase 2

Conditions studied: Post Traumatic Stress Disorder

In brief

A Phase 2, single-center, fixed-dose, open-label study will explore the efficacy, safety, and tolerability of a 120 mg dose of oral MDMA followed by a supplemental dose of 60 mg MDMA in conjunction with therapy in individual versus group settings for adult veterans diagnosed with PTSD.

Key facts

Study ID
NCT07569159
Run by
Sunstone Medical
People needed
52
Starts
2026-06-30
Expected to finish
2027-08-01
Last updated by the study team
2026-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.